New Delhi, July 13 -- BENGALURU - An Indian developer paying for Claude Pro today finds themselves spending Rs.2,000 a month on an annual plan - roughly $21 at current exchange rates - which is about ... Read More
Mumbai, July 13 -- Total revenue from operations jumped 22.38% YoY to Rs 5,212.92 crore in Q1 FY27. Profit before tax (PBT) climbed 31.07% YoY to Rs 943.22 crore in the quarter ended 30th June 2026. ... Read More
India, July 13 -- All it took was 115 mm of rain over two days to expose the cracks beneath Gurugram's gleaming skyline. Beyond its glass towers and corporate offices lay another Gurugram, where roads... Read More
Mumbai/IBNS, July 13 -- The Indian stock market witnessed a sharp sell-off on Monday, with benchmark indices plunging at the opening bell as investor sentiment remained under pressure amid the escalat... Read More
Mumbai, July 13 -- Stocks rose and oil prices eased Thursday as financial markets calmed in the wait to see what will come next after President Donald Trump raised doubts about the temporary truce in ... Read More
New Delhi, July 13 -- LONDON - Britain's crypto industry has spent years operating under a framework that promised clarity but delivered consultation papers. That changed this week. The Financial Con... Read More
New Delhi, July 13 -- Elon Musk's fortune fell below $900 billion on Monday as shares of SpaceX continued to erase gains, sliding closer to their public offering price. Shares of SpaceX dropped 4.45%... Read More
New Delhi, July 13 -- The Supreme Court on Monday refused to make any specific observations on whether, or to what extent, the central investigating agencies, including the Directorate of Enforcement ... Read More
Mumbai, July 13 -- The key equity barometers traded with limited losses in the morning trade as investor sentiment turned risk-averse following the escalation of the US-Iran conflict, which heightened... Read More
India, July 13 -- Today's top biotech gainers include Q32 Bio, following positive Phase 2 results for its hair loss treatment; Agenus, as it advances development of its colon cancer drug combination, ... Read More